about
Cardiac toxicity in cancer survivorsSuivi après le traitement du cancer du sein: Guide pratique des soins aux survivantes à l’intention des médecins de familleFollow-up after treatment for breast cancer: Practical guide to survivorship care for family physiciansScreening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric studyBreast cancer survivorship issues.Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatmentDiagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Survivorship: introduction and definition. Clinical practice guidelines in oncologyCuring Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss.Symptom burden and integrative medicine in cancer survivorship.Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.Health management in cancer survivors: Findings from a population-based prospective cohort study-the Yamagata Study (Takahata)Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.Cardiac dysfunction among soft tissue sarcoma patients in DenmarkAdvanced medullary thyroid cancer: pathophysiology and managementEvaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment.Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials.Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors.Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship.A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.Breast cancer therapy-associated cardiovascular disease.Exercise Training in Cancer Survivors.The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy.Cardio-oncology.Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.Home-Based Exercise Training Improves Left Ventricle Diastolic Function in Survivors of Childhood ALL: A Tissue Doppler and Velocity Vector Imaging Study.Lasting impact: understanding the psychosocial implications of cancer among military veterans.Breast cancer survivorship: state of the science.Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.Does low volume high-intensity interval training elicit superior benefits to continuous low to moderate-intensity training in cancer survivors?Cardio-Oncology - A new subspecialty with collaboration at its heart.Lung cancer as a cardiotoxic state: a review.Hypertension in malignancy-an underappreciated problem.
P2860
Q26851957-D8089F8C-CDA7-4B27-962C-586A465BF6E8Q28078524-06041CFA-407F-46F5-8C51-2F6305FC615DQ28080263-00741F30-8268-4CC7-BD5F-44372DEAC89EQ33876216-3E6F05B9-D53B-4EE7-84F0-D674A5069AABQ34669169-6857E616-E094-41A7-B2DF-0ABB3D880CADQ34895561-E87B4657-4DF2-4544-9782-0A5AA8DBD0FAQ35024342-B5EBDD69-C321-49E2-999E-386052615C12Q35396089-F09EFE2B-3F47-4B3D-973F-924427884922Q35490056-D7BB4472-83B7-4B4A-BE9B-440E78BC9E12Q35734924-C98783FD-E0C4-4FCF-A5C8-6D457A9E3A50Q35997676-8F027841-67F3-433A-8E0D-7E8C248CFEAAQ36004562-08213295-41D5-4197-A948-7FF0BBF4280BQ36099606-3D61D213-4CE7-4B7E-9D56-68ACF0DA9FAFQ36332458-0338CDDF-CD04-4009-9282-84455C791314Q36467480-E18F4314-CEB9-4C71-A520-0D26602B0246Q36615092-44B36597-BDEB-4A87-B438-F901F390E2B7Q36774819-175BF5DF-DFFB-4517-92B6-444B51166102Q36843212-6E9277FB-942A-40BA-A4A2-F5B206C0BDB3Q36857218-2733590A-4D4E-45A9-AC32-0F9FE4DB1EA9Q37017033-A250C99C-F9E3-40D0-8FCA-DD76CEE4A69BQ37316811-27988CEB-745C-4FC9-A431-60FDF4D0D915Q37494348-C8141626-A9A2-445E-8752-641D750699F8Q37628663-A3005A83-6681-41A5-94D5-A620E8368FAEQ38197733-1174C6A1-B682-4863-981D-E5E3C3877250Q38231301-831CE924-6C60-48BC-A3C2-033C2EBE5D90Q38545052-0E9FA69E-2498-4C85-AC57-FF8E50EF34B9Q38645182-AFE9B183-3F1D-41BB-BA3E-8D21BAFC8BADQ38828357-0BFE3139-7A7A-4416-93E7-C0B291A9BEC1Q38978144-A6DA2F88-A51D-43D4-9FE6-E817216647DAQ39076609-1961CA9D-6364-4219-99B7-FE23101AC439Q39241736-8F4CC35F-270D-441A-ADE4-3FAE96ED49DEQ40132680-8F2C7922-54A6-482E-B6FD-A0FAB1163673Q40745163-6AE2FEB2-A761-460F-9E12-AAC47BCB8DC9Q43603381-2193A323-B0AB-417F-BA4C-2EBF05C53013Q47560863-8603D661-83A5-41ED-A359-D63D59B70831Q48168034-E072A256-C45E-4499-8724-584EB22203F3Q50285596-A4EDB356-D94D-49DB-A4DC-C107F5143D0BQ53104651-2BAC27A0-D551-453C-B09F-98D1EF8F21F9Q53117997-1DC2636C-70CB-490C-BB0C-0B9584FF6505Q55071881-72E6423D-8E49-426F-B320-76D4962F47CC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Late cardiac effects of cancer treatment.
@ast
Late cardiac effects of cancer treatment.
@en
Late cardiac effects of cancer treatment.
@nl
type
label
Late cardiac effects of cancer treatment.
@ast
Late cardiac effects of cancer treatment.
@en
Late cardiac effects of cancer treatment.
@nl
prefLabel
Late cardiac effects of cancer treatment.
@ast
Late cardiac effects of cancer treatment.
@en
Late cardiac effects of cancer treatment.
@nl
P356
P1476
Late cardiac effects of cancer treatment.
@en
P2093
Daniel J Lenihan
Daniela M Cardinale
P304
P356
10.1200/JCO.2012.45.2938
P407
P577
2012-09-24T00:00:00Z